Pheton Holdings Ltd (NASDAQ:PTHL – Get Free Report) was the target of a large growth in short interest during the month of January. As of January 15th, there was short interest totaling 25,233 shares, a growth of 47.8% from the December 31st total of 17,067 shares. Based on an average trading volume of 7,384,767 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.4% of the company’s shares are sold short. Approximately 0.4% of the company’s shares are sold short. Based on an average trading volume of 7,384,767 shares, the days-to-cover ratio is presently 0.0 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Pheton in a report on Friday, October 31st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.
Read Our Latest Research Report on PTHL
Pheton Price Performance
Pheton Company Profile
Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.
See Also
- Five stocks we like better than Pheton
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Become a 2x better options trader (in 2 days)
Receive News & Ratings for Pheton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pheton and related companies with MarketBeat.com's FREE daily email newsletter.
